Condition: Traumatic Fracture · Pathological Fracture · Sponsor: IlluminOss Medical, Inc.
This is a multi-center, observational patient registry. The primary objective of the study is to collect safety and performance data on the IlluminOss Device when used to provide stabilization and alignment for the treatment of traumatic or impending and pathologic fractures.
This description comes directly from the study's public registry record.
Lisa Holt, PhD · 401-714-0008 · lholt@illuminoss.com
Caitlin Smith, MPH · 401-714-0008 · csmith@illuminoss.com
Always discuss trial participation with your own doctor first.
| Gulf Orthopedics | Mobile, Alabama, United States | Completed |
| Cedars-Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| Presbyterian St Luke's Medical Ctr | Denver, Colorado, United States | Recruiting |
| University of Miami Hospital | Miami, Florida, United States | Recruiting |
| Weston Outpatient Surgical Center | Weston, Florida, United States | Recruiting |
| Parkview Health | Fort Wayne, Indiana, United States | Withdrawn |
| Jacobi Medical Center | The Bronx, New York, United States | Recruiting |
| Mission Hospital | Asheville, North Carolina, United States | Withdrawn |
| Wake Forest Baptist Health | Winston-Salem, North Carolina, United States | Recruiting |
| Temple University Hospital | Philadelphia, Pennsylvania, United States | Recruiting |
| University of Pittsburgh Medical Center | Pittsburgh, Pennsylvania, United States | Recruiting |
| Ortho Rhode Island | Wakefield, Rhode Island, United States | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05206981